Nothing in this article constitutes medical advice, diagnosis, or treatment recommendation
Cagrilintide's dual profile has a preclinical rationale
Pyo HK, Yoo HG, Won CH, et al
"A synthetic tripeptide which increases survival of normal liver cells, and stimulates growth in hepatoma cells." Biochemical and Biophysical Research Communications
2020 Mar 27;2(1):58-61
Also, promotes anti-inflammation in the heart, improves insulin sensitivity, is neuroprotective, and reduces alcohol consumption GIP receptor activation enhances insulin secretion, stimulates glucagon to prevent low blood sugar, promotes bone mineral density, is neuroprotective, and lowers blood pressure GCG receptor activation promotes fat metabolism, reduces liver fat, is anti-inflammatory, and increases basal metabolic rate Dosing Subcutaneous 2 mg 16 mg Once a week Morning preferred Healing & Recovery BPC-157 Body Protection Compound (BPC)-157